Viking Global Opportunities Illiquid Investments Sub-Master LP, 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX), sold 2,800,000 shares at $30.59 ($83.4M) on 2022-09-08, disclosed to the SEC on 2022-09-09.
Open-market sale of $83.4M AMLX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.28 | 38,116 | $1.0M | 1.2% |
| 2 | $27.28 | 38,116 | $1.0M | 1.2% |
| 3 | $27.28 | 80,715 | $2.2M | 2.6% |
| 4 | $27.28 | 80,715 | $2.2M | 2.6% |
| 5 | $28.16 | 51,298 | $1.4M | 1.7% |
| 6 | $28.16 | 108,631 |
| $3.1M |
| 3.7% |
| 7 | $28.16 | 108,631 | $3.1M | 3.7% |
| 8 | $28.16 | 51,298 | $1.4M | 1.7% |
| 9 | $29.14 | 159,026 | $4.6M | 5.6% |
| 10 | $29.14 | 159,026 | $4.6M | 5.6% |
| 11 | $29.14 | 75,096 | $2.2M | 2.6% |
| 12 | $29.14 | 75,096 | $2.2M | 2.6% |
| 13 | $30.59 | 7,554 | $231K | 0.3% |
| 14 | $30.59 | 15,996 | $489K | 0.6% |
| 15 | $30.59 | 7,554 | $231K | 0.3% |
| 16 | $30.59 | 15,996 | $489K | 0.6% |
| 17 | $32.23 | 111,102 | $3.6M | 4.3% |
| 18 | $32.23 | 52,466 | $1.7M | 2.0% |
| 19 | $32.23 | 52,466 | $1.7M | 2.0% |
| 20 | $32.23 | 111,102 | $3.6M | 4.3% |
| 21 | $29.87 | 312,353 | $9.3M | 11.2% |
| 22 | $29.87 | 147,502 | $4.4M | 5.3% |
| 23 | $29.87 | 147,502 | $4.4M | 5.3% |
| 24 | $29.87 | 312,353 | $9.3M | 11.2% |
| 25 | $30.90 | 73,886 | $2.3M | 2.7% |
| 26 | $30.90 | 73,886 | $2.3M | 2.7% |
| 27 | $30.90 | 156,463 | $4.8M | 5.8% |
| 28 | $30.90 | 156,463 | $4.8M | 5.8% |
| 29 | $31.44 | 6,654 | $209K | 0.3% |
| 30 | $31.44 | 3,142 | $99K | 0.1% |
| 31 | $31.44 | 6,654 | $209K | 0.3% |
| 32 | $31.44 | 3,142 | $99K | 0.1% |
| Total | $29.80 avg | 2,800,000 | $83.4M | 100% |
| Filing → |
| FDMT | SELL | 2024-01-05 | $10.5M | — | Filing → |
| AMLX | BUY | 2022-01-13 | $43.7M | — | Filing → |
| RLYB | BUY | 2021-08-02 | $10.5M | — | Filing → |